A cross-sectional survey of vancomycin-resistant gram-positive cocci (VRGPC) in the feces of children was initiated after several bacteremic infections with these organisms occurred at our hospital. A selective medium consisting of colistin-nalidixic acid agar, 5% sheep blood, vancomycin (5 mg/liter), and amphotericin B (8 mg/liter) was developed to isolate VRGPC. A single stool specimen submitted to the clinical microbiology laboratory from each of 48 patients was inoculated onto the medium. Plates were incubated at 35°C with 5% carbon dioxide and examined at 24, 48, and 72 h. Susceptibilities were determined by broth microdilution. A total of 14 isolates from 11 of 48 (22%) children were recovered. The density of growth ranged from a single colony to 2+. The VRGPC were identified as Leuconostoc lactis (n = 2), Lactobacillus confusus (n = 4), Enterococcus species (n = 5), and Lactococcus lactis (n = 3). One strain of Lactobacillus confusus was recovered from both the stool and the blood of one of these patients. The MICs of vancomycin were 4 ,ug/ml for one of the isolates, 8 ,g/ml for four of the isolates, and more than 16 ,ug/ml for the remaining eight isolates. Ail isolates were susceptible to both penicillin and ampicillin. Only 1 of the 11 children had received prior treatment with vancomycin. We conclude that low concentrations of VRGPC may be common in the gastrointestinal tracts of children.
Resistance to vancomycin among gram-positive cocci was previously thought to be rare. Several recent reports, however, suggest the emergence of this resistance (1, 7, 9, 12, 15, 18) . Shlaes et al. (15) described an episode, in an oncology patient, of bacteremia caused by Streptococcus sanguis Il which was resistant to vancomycin. Another case of bacteremia caused by a vancomycin-resistant bacterium was reported by Rubin et al. (12) . The isolate was initially identified as a Streptococcus salivarius-like bacterium, but more detailed testing revealed the isolate to be Leuconostoc mesenteroides. Several additional reports have also documented episodes of bacteremia associated with vancomycinresistant Leuconostoc spp., several of which have occurred in children (1, 2, (5) (6) (7) 18) . Furthermore, mechanisms of resistance have been suggested. Leclercq et al. (9) reported that vancomycin resistance was associated with a plasmid in an enterococcal isolate, confirming that such resistance occurs.
The actual incidence of infections caused by vancomycinresistant gram-positive cocci (VRGPC) is unknown, since many clinical laboratories neither routinely employ identification schema to differentiate Leuconostoc species from viridans group streptococci nor routinely determine the susceptibilities of clinical isolates of viridans group streptococci to vancomycin. Furthermore, the frequency of representation of these bacteria in the indigenous normal flora of humans has not been established. Ruoff et al. (13) reported that 6 of 10 Leuconostoc isolates were cultured from sites contiguous to the gastrointestional tract. This finding suggests that the gastrointestional tract may serve as a reservoir of colonization and, by means of bacterial translocation (17) , may also serve as a source of infection. The were subjected to a battery of identification tests including tion by the autoclave method (12) . Motility was then detercatalase, gas production in MRS broth overlaid with 2% agar mined on those strains identified as Enterococcus (16) 16 ,ug/ml was considered moderately susceptible, and more than 16 p.g/ml was considered resistant (11) .
Because of the poor growth of many of the VRGPC in both CSMHB and THB as well as the lack of growth of several strains of lactic acid bacteria in CSMHB with lysed horse blood, we assessed the feasibility of performing susceptibility testing, using MRS broth as we used standard broths (CSMHB and THB). The 4 ,ug/ml.
The susceptibilities of the three Lactococcus isolates and seven Leuconostoc or Lactobacillus isolates could not be reliably determined at 24 h because of poor growth in both CSMHB and THB. Enhanced growth was seen at 24 h when CSMHB with lysed horse blood was used for these isolates; however, one strain of lactococcus and another of lactobacillus failed to grow in this broth. MICs for the lactococci were slightly higher in CSMHB and CSMHB with lysed The enterococcal isolates identified in this study were moderately susceptible to vancomycin (MIC range, 4 to 16 ,ug/ml). This pattern of susceptibility differs from the highlevel resistance of .128 ,xg/ml found by Leclercq et al. (9) and may be attributed to a mechanism of resistance which is not plasmid mediated. The MIC for Enterococcus gallinarum (8 ptg/ml) seen in our three strains is identical to that found by Swenson et al. (16) for six strains of this species. They speculated that Enterococcus gallinarum is inherently more resistant to vancomycin than are other species of enterococci. It is also possible that this pattern of intermediate susceptibility may be inducible to high-level resistance upon exposure to vancomycin. Williamson et al. (19) have recently reported an initial MIC for an isolate of Enterococcus faecium which was 16 ,ugIml, with inducible high-level resistance to -128 ,ug/ml. As in the isolates of Leclercq et al., the low-level resistance could be cured but was associated with a different-molecular-weight protein than that seen in isolates with high-level resistance (14) .
Susceptibility testing of isolates of VRGPC can be performed with a commercial microtiter system. The slow growth of Leuconostoc or Lactobacillus spp., as well as that of the lactococci, may require delaying the visual reading of susceptibilities until 48 h. The use of CSMHB with lysed horse blood enhanced growth in most isolates, but no growth was seen in two of nine isolates repeatedly tested with this broth. Alternatively, all of our isolates grew extremely well in MRS broth, with clear, readable endpoints at 24 h. The increased acidity of this medium may cause some difficulty with certain antibiotics. Although the effect of increased acidity is not known for all antimicrobial agents, higher MICs of erythromycin, gentamicin, and trimethoprim-sulfamethoxazole were noted. However, no difference in the interpretation of the susceptibility test with either MRS broth or CSMHB or THB for antibiotics that the National Committee for Clinical Laboratory Standards suggests testing was found, in either our isolates or the American Type Culture Collection strains that we evaluated. Although further experience with susceptibility testing in this broth is needed, these data suggest that MRS broth may be an alternate medium for use in testing of the susceptibilities of these slow-growing organisms when conventional media provide insufficient growth.
Finally, the identification of our bacteremic isolates of VRGPC would not have occurred if testing of susceptibility to vancomycin had not been performed. Clinical laboratories should perform routine tests of susceptibility to vancomycin for clinical isolates which resemble the viridans group streptococci. Furthermore, the laboratory should consider differentiating Leuconostoc or Lactobacillus spp. from streptococci in cases in which resistance to vancomycin is identified so that the importance of VRGPC in clinical disease can be determined.
